Table 1.
Sex and race/ethnic representation in the original studies supporting the 2021 Surviving Sepsis Campaign guidelines
| Recommendations | Studies (n) |
Sample size (n) | Males1 n (%) |
Reported race2 n (%) |
White3 n (%) |
Black3 n (%) |
Hispanic3 n (%) |
Others3 n (%) |
|---|---|---|---|---|---|---|---|---|
| Screening & Early Treatment | 30 | 2,741,771 |
1,300,889 (48) |
5 (17) |
793,221 (68) |
193,612 (17) |
94,769 (9) |
81,421 (7) |
| Infection | 126 | 779,053 |
424,672 (61) |
21 (17) |
134,091 (73) |
28,320 (16) |
2,861 (12) |
17,731 (10) |
| Hemodynamic Management | 47 | 68,939 |
37,531 (56) |
10 (21) |
32,623 (74) |
3,508 (14) |
3 (15) |
4,049 (17) |
| Ventilation | 41 | 28,683 |
13,732 (62) |
6 (15) |
2,178 (74) |
390 (16) |
205 (9) |
57 (4) |
| Additional Therapies | 36 | 232,790 |
123,081 (54) |
5 (14) |
1057 (77) |
181 (19) |
30 (5) |
40 (4) |
|
Long Term Outcomes/ Goals of Care |
83 | 2,508,901 |
1,183,748 (47) |
30 (36) |
838,323 (71) |
209,136 (17) |
87,554 (8) |
42,648 (4) |
1Some studies may not have reported the sex; the proportion of males reflects the proportion from the studies that reported sex
2Refers to the number of studies that had race reported in the patient characteristics
3Refers to the proportion based on the studies that reported each of the listed race/ethnicity; total may not add up to 100% given that there is inconsistency in the race/ethnicity reported by each study